Breath test for fungal infections in leukemia patients
Part of Blood & lymphatic, Cancer, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This trial tests if a simple breath analysis can detect invasive fungal infections early in people with acute leukemia who are undergoing chemotherapy and have a low white blood cell count. Early detection could help start treatment sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute leukemia.
- You are scheduled to receive chemotherapy that will require you to be in the hospital for at least 2 weeks.
- You currently have a very low white blood cell count (less than 500 per microliter) or are expected to have this low count for more than 7 days during chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to detect invasive lung aspergillosis earlier by testing samples from your lungs and measuring specific lab markers. It may help doctors start the right antifungal treatment sooner when the infection is suspected.
This study uses a special machine to analyze exhaled breath to learn about different illnesses in children and teens. It may help researchers find breathing “signals” that reflect conditions like breathing problems, nervous system issues, or new/worsening type 1 diabetes.
This study tests whether a quick breath test can detect infections early in people receiving intensive treatment for certain blood cancers or bone marrow transplant patients. If it works, it could help doctors find infections faster and adjust treatment sooner.
This trial checks if a blood test can find a fungal lung infection in people with blood cancers or those who had a stem cell transplant. The test looks for fungal DNA in the blood (called mNGS). If it works, it could help doctors diagnose the infection faster and more accurately.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study tests a new breath analysis method to quickly diagnose respiratory infections in ICU patients on breathing machines. If successful, it could lead to faster treatment for serious lung conditions.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.